Pharmaceutical News

RSS

The Pill Club reaches $18.3 million Medicaid fraud settlement with California

The Pill Club reaches $18.3 million Medicaid fraud settlement with California

The Pill Club, an online women's pharmacy, has reached an $18.3 million settlement with California authorities over claims it defrauded the state's Medicaid program by prescribing birth control pills without adequate consultation and shipping tens of thousands of female condoms to customers who didn't want them.

7 Feb 2023

Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5

Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5

In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers analyzed data from the Increasing Community Access to Testing (ICATT), a nationwide pharmacy program run in the US for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing.

7 Feb 2023

Mucoactive drugs block SARS-CoV-2 infection

Mucoactive drugs block SARS-CoV-2 infection

Researchers evaluate the effects of mucociliary active molecules on SARS-CoV-2 infection in vitro.

7 Feb 2023

VUMC’s Shed-MEDS protocol reduces exposure to potentially inappropriate medications

VUMC’s Shed-MEDS protocol reduces exposure to potentially inappropriate medications

An estimated one in six older adults in the United States who take multiple prescription drugs risk major drug-drug interactions and other adverse drug effects that can worsen their medical conditions, increase the likelihood of cognitive impairment and falls, and lead to hospitalization or death.

6 Feb 2023

Gut hormone receptor polyagonists show promise for obesity and diabetes

Gut hormone receptor polyagonists show promise for obesity and diabetes

A new paper in the Journal of Clinical Investigation describes drugs that could help lose weight and manage type 2 diabetes mellitus (T2DM).

6 Feb 2023

The effectiveness of intranasal COVID-19 vaccination in healthy adults

The effectiveness of intranasal COVID-19 vaccination in healthy adults

A recent study discusses the safety profiles and immunogenicity of the nasal BBV154 COVID-19 vaccine in healthy adults.

3 Feb 2023

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients

Patients with glioblastoma-;the deadliest type of primary brain tumor-;may potentially benefit from immunotherapy medications called immune checkpoint inhibitors that stimulate an immune response against cancer cells.

2 Feb 2023

Pfizer COVID-19 vaccine protects against reinfection in long-term care facility staff

Pfizer COVID-19 vaccine protects against reinfection in long-term care facility staff

Researchers examines the effectiveness of the Pfizer-BioNTech COVID-19 vaccine among long-term care facility staff members.

2 Feb 2023

Some antidepressants may be effective in treating chronic pain, but others lack effectiveness

Some antidepressants may be effective in treating chronic pain, but others lack effectiveness

New research has found some antidepressants may be effective in treating certain chronic pain conditions, but others lack convincing evidence on their effectiveness.

1 Feb 2023

A more nuanced approach is needed when prescribing antidepressants for pain, researchers say

A more nuanced approach is needed when prescribing antidepressants for pain, researchers say

Some antidepressant drugs are effective for some pain conditions, but most are either ineffective or the evidence is inconclusive, despite being used for a range of pain conditions, finds an overview of the latest evidence published by The BMJ today.

1 Feb 2023

Repeated COVID-19 vaccination may improve public health outcomes

Repeated COVID-19 vaccination may improve public health outcomes

A recent study suggests that repeated vaccination at frequent intervals might improve COVID-19 vaccine efficacy and the trajectory of the pandemic.

1 Feb 2023

Use of β-blockers linked with reductions in violence

Use of β-blockers linked with reductions in violence

Reductions in violence are seen in individuals using Beta adrenergic-blocking agents (β-blockers) compared with periods that they are not taking the medication, in a study published January 31st in the open access journal PLOS Medicine.

31 Jan 2023

Antiviral activity of natural flavonoids against various coronaviruses

Antiviral activity of natural flavonoids against various coronaviruses

A recent study describes the binding affinity and docking sites of several natural compounds, as well as their inhibitory activity against 3CLpro.

29 Jan 2023

Montana pharmacists may get more power to prescribe

Montana pharmacists may get more power to prescribe

Mark Buck, a physician and pharmacist in Helena, Montana, said he's been seeing more patients turn to urgent care clinics when they run out of medication.

27 Jan 2023

Updated bivalent mRNA booster protects against circulating SARS-CoV-2 variants

Updated bivalent mRNA booster protects against circulating SARS-CoV-2 variants

Researchers discuss the efficacy of the bivalent COVID-19 vaccine against symptomatic infection with SARS-CoV-2 variants.

25 Jan 2023

Pembrolizumab offers major added survival benefit for patients with advanced cervical cancer

Pembrolizumab offers major added survival benefit for patients with advanced cervical cancer

Pembrolizumab has recently been approved in combination with chemotherapy for the treatment of women with persistent, recurrent, or metastatic cervical cancer whose tumors express PD-L1. Chemotherapy with or without bevacizumab is possible.

25 Jan 2023

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

In a recent study posted to medRxiv*, researchers in Denmark examined the risk of adverse events after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron-based bivalent booster vaccination.

24 Jan 2023

Scientists reveal why common anti-depressants cause emotional ‘blunting’ in users

Scientists reveal why common anti-depressants cause emotional ‘blunting’ in users

Scientists have worked out why common anti-depressants cause around a half of users to feel emotionally 'blunted'.

23 Jan 2023

Potent small-molecule inhibitors against SARS-CoV, MERS-CoV, and SARS-CoV-2

Potent small-molecule inhibitors against SARS-CoV, MERS-CoV, and SARS-CoV-2

In a recent study posted to bioRxiv* preprint server, researchers in the United States identified several potent pan-coronavirus (CoV) inhibitors.

23 Jan 2023

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

In a recent study published in The Lancet Microbe journal, researchers described the effectiveness of a modular capsid virus-like coronavirus disease 2019 (COVID-19) vaccination.

22 Jan 2023

Previous
1
...
59
60
61
62
63
64
65
...
1433
Next

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.